Lynch Christopher S.
SEC Form 4 insider trading activity
Lynch Christopher S. has filed 4 SEC Form 4 filings (16 transaction rows) across 2 companies, including THC, CRBG, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jul 29, 2026.
On the most recent filing, Lynch Christopher S. is listed as Director at TENET HEALTHCARE CORP. Inside the rolling window, Lynch Christopher S. reported no open-market purchases and 1 open-market sale totaling $934K in THC.
Companies traded
Other insiders at THC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$934K
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Aug 28, 2025 | THC | Sale | $1K |
Frequently asked questions
How many SEC Form 4 filings has Lynch Christopher S. made?
Lynch Christopher S. has filed 4 SEC Form 4 filings (16 transaction rows) across 2 companies, including THC, CRBG since 2025.
Which companies does Lynch Christopher S. trade?
Lynch Christopher S. has filed SEC Form 4 disclosures for 2 companies, including THC, CRBG.
When was Lynch Christopher S.'s most recent SEC Form 4 filing?
Lynch Christopher S.'s most recent SEC Form 4 filing on Tracefour is dated Jul 29, 2026.
What is Lynch Christopher S.'s total buy and sell value in the current window?
Inside the rolling retention window, Lynch Christopher S. bought $0 and sold $934K based on SEC Form 4 filings.
What was Lynch Christopher S.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,837 THC shares on 2026-07-27, worth $934K, per SEC Form 4 filings.